For pharma & benefits partners
A structured prescribing pathway for your GI portfolio
The clinic puts qualified patients in front of prescribing physicians with digital adherence support already built in — drug-agnostic by design, with a specialty-access layer built for a biologic.
A qualified patient pipeline
Every patient is screened, symptom-confirmed, and lab-worked up before reaching a prescriber — not a cold referral.
An integrated prescribing moment
Medications are prescribed within a structured multimodal protocol, not as a last resort — creating consistent, documented prescribing opportunities.
Adherence amplified by digital therapy
Gut-directed hypnotherapy and CBT address the behavioural drivers of non-adherence, tracked as real session-completion data.
Delivery & infusion coordination
Cold-chain direct-to-patient shipment and infusion-clinic coordination remove the access barriers that cause abandonment.
Why it works for the people who pay for care
Canadians living with IBS
2.5M+
Receive guideline-aligned care
1 in 3
Lower all-cause cost at 12mo*
$6,081
GI-related ED visits, same cohort*
−68%
*Illustrative value drivers from a real-world virtual multidisciplinary GI care study; the clinic plans to validate cost-offset in its own registry cohort. Specific commercial terms vary by partner and market.
Next steps
We'd welcome a conversation about your organization's strategic priorities in brand differentiation and real-world-evidence generation, and a follow-up to discuss a virtual clinic strategy for your portfolio.